Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2023 Results
09 Januar 2024 - 2:30PM
DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq:
XRAY) will present at the 42nd Annual J.P. Morgan Healthcare
Conference on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am
ET). As part of the conference, the Company is providing an update
on its 2023 full year anticipated financial results, with net sales
expected to be at or above the high end of the Company’s previously
provided outlook range of $3.90 billion to $3.94 billion. For the
full year and fourth quarter 2023, the Company expects to report
year-over-year net sales growth in the Essential Dental Solutions,
Wellspect Healthcare, and Orthodontic and Implant Solutions
segments, partially offset by declines in the Connected Technology
Solutions segment. The Company is reaffirming its full year 2023
adjusted EPS outlook range of $1.80 to $1.85 and its expectations
for double-digit adjusted EPS growth in 2024. The Company does not
provide forward-looking or preliminary estimates of adjusted EPS on
a GAAP basis as certain information needed to prepare adjustments
is not yet available and cannot be reasonably estimated. A
description of the adjustments typically made to compute adjusted
EPS can be found in Exhibit 99.1 to the Company’s Current Report on
Form 8-K filed on November 2, 2023.
The preliminary estimates above are based solely upon
information available to management as of the date of this press
release and are subject to change. The Company’s actual results may
differ from this estimate due to the completion of its year-end
closing procedures, final adjustments and developments that may
arise or information that may become available between now and the
time the Company’s financial results are finalized and included in
its Annual Report on Form 10-K for the year ended December 31,
2023.
Presentation materials and webcast information
for the investor conference, including a replay of the webcast
following the conference, is available on the Investors section of
the Dentsply Sirona website at
https://investor.dentsplysirona.com.
About Dentsply Sirona
Dentsply Sirona is the world’s largest manufacturer of
professional dental products and technologies, with over a century
of innovation and service to the dental industry and patients
worldwide. Dentsply Sirona develops, manufactures, and markets a
comprehensive solution offering including dental and oral health
products as well as other consumable medical devices under a strong
portfolio of world class brands. Dentsply Sirona’s products provide
innovative, high-quality and effective solutions to advance patient
care and deliver better and safer dental care. Dentsply Sirona’s
headquarters is located in Charlotte, North Carolina. The Company’s
shares are listed in the United States on Nasdaq under the symbol
XRAY. Visit www.dentsplysirona.com for more information about
Dentsply Sirona and its products.
Contact Information:
Investors:Andrea DaleyVice President, Investor
Relations+1-704-805-1293InvestorRelations@dentsplysirona.com
Forward-Looking Statements and Associated
Risks
This Press Release contains statements that do not directly and
exclusively relate to historical facts which constitute
forward-looking statements, including statements and projections
concerning financial performance. The Company’s forward-looking
statements represent current expectations and beliefs and involve
risks and uncertainties. Actual results may differ significantly
from those projected or suggested in any forward-looking statements
and no assurance can be given that the results described in such
forward-looking statements will be achieved. Investors are
cautioned not to place undue reliance on such forward-looking
statements which speak only as of the date they are made. The
forward-looking statements are subject to numerous assumptions,
risks and uncertainties and other factors that could cause actual
results to differ materially from those described in such
statements, many of which are outside of our control. The Company
does not undertake any obligation to release publicly any revisions
to such forward-looking statements to reflect events or
circumstances occurring after the date hereof or to reflect the
occurrence of unanticipated events. Any number of factors could
cause the Company’s actual results to differ materially from those
contemplated by any forward-looking statements, including, but not
limited to, the risks associated with the following: the Company’s
ability to remain profitable in a very competitive marketplace,
which depends upon the Company’s ability to differentiate its
products and services from those of competitors; the Company’s
failure to realize assumptions and projections which may result in
the need to record additional impairment charges; the effect of
changes to the Company’s distribution channels for its products and
the failure of significant distributors of the Company to
effectively manage their inventories; the Company’s ability to
control costs and failure to realize expected benefits of cost
reduction and restructuring efforts and the Company’s failure to
anticipate and appropriately adapt to changes or trends within the
rapidly changing dental industry. Investors should carefully
consider these and other relevant factors, including those risk
factors in Part I, Item 1A, (“Risk Factors”) in the Company’s most
recent Annual Report on Form 10-K, including any amendments
thereto, and any updating information which may be contained in the
Company’s other filings with the Securities and Exchange Commission
(“SEC”), when reviewing any forward-looking statement. The Company
notes these factors for investors as permitted under the Private
Securities Litigation Reform Act of 1995. Investors should
understand it is impossible to predict or identify all such factors
or risks. As such, you should not consider either the foregoing
lists, or the risks identified in the Company’s SEC filings, to be
a complete discussion of all potential risks or uncertainties.
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
Von Jun 2023 bis Jun 2024